Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts

Genes and Development

Volumn 28, Issue 9, 2014, Pages 943-958

  Esnault, Cyril ^a   Stewart, Aengus ^a   Gualdrini, Francesco ^a   East, Phil ^a   Horswell, Stuart ^a   Matthews, Nik ^a   Treisman, Richard ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Chromatin; MRTF; Rho; Signal transduction; SRF; TCF

Indexed keywords

ACTIN; MYOCARDIN RELATED TRANSCRIPTION FACTOR; RHO FACTOR; RNA POLYMERASE; RNA POLYMERASE II; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL GROWTH; CHROMATIN IMMUNOPRECIPITATION; CIRCADIAN RHYTHM; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; DNA BINDING; DYNAMICS; FIBROBLAST; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; STIMULATION;

CHROMATIN; MRTF; RHO; SIGNAL TRANSDUCTION; SRF; TCF;

ACTINS; ANIMALS; CIRCADIAN CLOCKS; CLOCK PROTEINS; FIBROBLASTS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PERIOD CIRCADIAN PROTEINS; SERUM; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84899734505     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.239327.114     Document Type: Article

References (54)

1. Akashi M., Nishida E. 2000. Involvement of the MAP kinase cascade in resetting of the mammalian circadian clock. Genes Dev 14: 645-649.
2. Anders S., Huber W. 2010. Differential expression analysis for sequence count data. Genome Biol 11: R106.
3. Balamotis M. A, Pennella MA, Stevens JL, Wasylyk B, Belmont AS, Berk AJ. 2009. Complexity in transcription control at the activation domain-mediator interface. Sci Signal 2: ra20.
4. Balsalobre A., Damiola F, Schibler U. 1998. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93: 929-937.
5. Barker H. E, Cox TR, Erler JT. 2012. The rationale for targeting the LOX family in cancer. Nat Rev Cancer 12: 540-552.
6. Boros J., Donaldson IJ, O'Donnell A, Odrowaz ZA, Zeef L, Lupien M, Meyer CA, Liu XS, Brown M, Sharrocks AD. 2009. Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. Genome Res 19: 1963-1973.
7. Boyes J., Felsenfeld G. 1996. Tissue-specific factors additively increase the probability of the all-or-none formation of a hypersensitive site. EMBO J 15: 2496-2507.
8. Butcher D. T, Alliston T, Weaver VM. 2009. A tense situation: forcing tumour progression. Nat Rev Cancer 9: 108-122.
9. Calvo F., Ege N, Grande-Garcia A, Hooper S, Jenkins RP, Chaudhry S. I, Harrington K, Williamson P, Moeendarbary E, CharrasG, et al. 2013. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol 15: 637-646.
10. Chen J., Yuan K, Mao X, Miano JM, Wu H, Chen Y. 2012. Serum response factor regulates bone formation via IGF-1 and Runx2 signals. J Bone Miner Res 27: 1659-1668.
11. Costello P., Nicolas R, Willoughby J, Wasylyk B, Nordheim A, Treisman R. 2010. Ternary complex factors SAP-1 and Elk-1, but not net, are functionally equivalent in thymocyte development. J Immunol 185: 1082-1092.
12. Discher D. E, Mooney DJ, Zandstra PW. 2009. Growth factors, matrices, and forces combine and control stem cells. Science 324: 1673-1677.
13. Dupont S., Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F., Le Digabel J, ForcatoM, Bicciato S, et al. 2011. Role of YAP/TAZ in mechanotransduction. Nature 474: 179-183.
14. The ENCODE Project Consortium. 2007. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
15. The ENCODE Project Consortium. 2011. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 9: e1001046.
16. Gerber A., Esnault C, Aubert G, Treisman R, Pralong F, Schibler U. 2013. Blood-borne circadian signal stimulates daily oscillations in actin dynamics and SRF activity. Cell 152: 492-503.
17. Gineitis D., Treisman R. 2001. Differential usage of signal transduction pathways defines two types of serum response factor target gene. J Biol Chem 276: 24531-24539.
18. Heinz S., Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576-589.
19. Herrera R. E, Shaw PE, Nordheim A. 1989. Occupation of the c-fos serum response element in vivo by a multi-protein complex is unaltered by growth factor induction. Nature 340: 68-70.
20. Ho C. Y, Jaalouk DE, Vartiainen MK, Lammerding J. 2013. Lamin A/C and emerin regulate MKL1-SRF activity by modulating actin dynamics. Nature 497: 507-511.
21. Hollenhorst P. C, McIntosh LP, Graves BJ. 2011. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 80: 437-471.
22. Huang D. W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
23. Huang X., Yang N, Fiore VF, Barker TH, Sun Y, Morris SW, Ding Q, Thannickal VJ, Zhou Y. 2012. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. Am J Respir Cell Mol Biol 47: 340-348.
24. Johansen F. E, Prywes R. 1993. Identification of transcriptional activation and inhibitory domains in serum response factor (SRF) by using GAL4-SRF constructs. Mol Cell Biol 13: 4640-4647.
25. Kim T. K, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, Harmin D. A, Laptewicz M, Barbara-Haley K, Kuersten S, et al. 2010. Widespread transcription at neuronal activityregulated enhancers. Nature 465: 182-187.
26. Koike N., Yoo SH, Huang HC, Kumar V, Lee C, Kim TK, Takahashi J.S. 2012. Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. Science 338: 349-354.
27. Krendel M., Zenke FT, Bokoch GM. 2002. Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton. Nat Cell Biol 4: 294-301.
28. Kwon Y., Vinayagam A, Sun X, Dephoure N, Gygi SP, Hong P, Perrimon N. 2013. The Hippo signaling pathway interactome. Science 342: 737-740.
29. Lammerding J., Fong LG, Ji JY, Reue K, Stewart CL, Young SG, Lee R.T. 2006. Lamins A and C but not lamin B1 regulate nuclear mechanics. J Biol Chem 281: 25768-25780.
30. Leitner L., Shaposhnikov D, Mengel A, Descot A, Julien S, Hoffmann R., Posern G. 2011. MAL/MRTF-A controls migration of non-invasive cells by upregulation of cytoskeletonassociated proteins. J Cell Sci 124: 4318-4331.
31. Loven J., Orlando DA, Sigova AA, Lin CY, Rahl PB, Burge CB, Levens D. L, Lee TI, Young RA. 2012. Revisiting global gene expression analysis. Cell 151: 476-482.
32. Medjkane S., Perez-Sanchez C, Gaggioli C, Sahai E, Treisman R. 2009. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat Cell Biol 11: 257-268.
33. Mikkelsen T. S, Xu Z, Zhang X, Wang L, Gimble JM, Lander ES, Rosen E.D. 2010. Comparative epigenomic analysis of murine and human adipogenesis. Cell 143: 156-169.
34. Miralles F., Posern G, Zaromytidou AI, Treisman R. 2003. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113: 329-342.
35. Mokalled M. H, Johnson A, Kim Y, Oh J, Olson EN. 2010. Myocardin-related transcription factors regulate the Cdk5/ Pctaire1 kinase cascade to control neurite outgrowth, neuronal migration and brain development. Development 137: 2365-2374.
36. Morita T., Mayanagi T, Sobue K. 2007. Dual roles of myocardinrelated transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J Cell Biol 179: 1027-1042.
37. Obrietan K., Impey S, Storm DR. 1998. Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei. Nat Neurosci 1: 693-700.
38. Olson E. N, Nordheim A. 2010. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol 11: 353-365.
39. Paszek M. J, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A., Reinhart-King CA, Margulies SS, Dembo M, Boettiger D., et al. 2005. Tensional homeostasis and the malignant phenotype. Cancer Cell 8: 241-254.
40. Posern G., Treisman R. 2006. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol 16: 588-596.
41. Provenzano P. P, Inman DR, Eliceiri KW, Beggs HE, Keely PJ. 2008. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. Am J Pathol 173: 1551-1565.
42. Provenzano P. P, Inman DR, Eliceiri KW, Keely PJ. 2009. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 28: 4326-4343.
43. Qiu P., Ritchie RP, Fu Z, Cao D, Cumming J, Miano JM, Wang DZ, Li HJ, Li L. 2005. Myocardin enhances Smad3-mediated transforming growth factor-β1 signaling in a CArG boxindependent manner: Smad-binding element is an important cis element for SM22αtranscription in vivo. Circ Res 97: 983-991.
44. Sordella R., Jiang W, Chen GC, Curto M, Settleman J. 2003. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 113: 147-158.
45. Sullivan A. L, Benner C, Heinz S, Huang W, Xie L, Miano JM, Glass C.K. 2011. Serum response factor utilizes distinct promoter-and enhancer-based mechanisms to regulate cytoskeletal gene expression in macrophages. Mol Cell Biol 31: 861-875.
46. Swift J., Ivanovska IL, Buxboim A, Harada T, Dingal PC, Pinter J, Pajerowski J. D, Spinler KR, Shin JW, Tewari M, et al. 2013. Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation. Science 341: 1240104.
47. Thurman R. E, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E., Sheffield NC, Stergachis AB, Wang H, Vernot B, et al. 2012. The accessible chromatin landscape of the human genome. Nature 489: 75-82.
48. Valouev A., Johnson DS, Sundquist A, Medina C, Anton E, Batzoglou S., Myers RM, Sidow A. 2008. Genome-wide analysis of transcription factor binding sites based on ChIPSeq data. Nat Methods 5: 829-834.
49. Vartiainen M. K, Guettler S, Larijani B, Treisman R. 2007. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science 316: 1749-1752.
50. Wang D., Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN. 2001. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105: 851-862.
51. Wang Z., Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson E.N. 2004. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428: 185-189.
52. Yu F. X, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, et al. 2012. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150: 780-791.
53. Zaromytidou A. I, Miralles F, Treisman R. 2006. MAL and ternary complex factor use different mechanisms to contact a common surface on the serum response factor DNAbinding domain. Mol Cell Biol 26: 4134-4148.
54. Zhang Y., Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, et al. 2008. Model-based analysis of ChIP-seq (MACS). Genome Biol 9: R137.